Report for Lanzafame A

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (8)

Title : Investigation of the interaction of a putative allosteric modulator, N-(2,3-diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) methanamine hydrobromide (SCH-202676), with M1 muscarinic acetylcholine receptors - Lanzafame_2004_J.Pharmacol.Exp.Ther_308_830
Author(s) : Lanzafame A , Christopoulos A
Ref : Journal of Pharmacology & Experimental Therapeutics , 308 :830 , 2004
Abstract : Lanzafame_2004_J.Pharmacol.Exp.Ther_308_830
ESTHER : Lanzafame_2004_J.Pharmacol.Exp.Ther_308_830
PubMedSearch : Lanzafame_2004_J.Pharmacol.Exp.Ther_308_830
PubMedID: 14617684

Title : The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria - Lanzafame_2001_Eur.J.Pharmacol_416_235
Author(s) : Lanzafame A , Christopoulos A , Mitchelson F
Ref : European Journal of Pharmacology , 416 :235 , 2001
Abstract : Lanzafame_2001_Eur.J.Pharmacol_416_235
ESTHER : Lanzafame_2001_Eur.J.Pharmacol_416_235
PubMedSearch : Lanzafame_2001_Eur.J.Pharmacol_416_235
PubMedID: 11290374

Title : Poster: The interaction of otenzepad (AF-DX 116) with allosteric modulators and competitive antagonists at a muscarinic M2 receptor -
Author(s) : Mitchelson F , Lanzafame A , Christopoulos A
Ref : Life Sciences , 64 :559 , 1999
PubMedID:

Title : Allosteric interactions at muscarinic cholinoceptors - Christopoulos_1998_Clin.Exp.Pharmacol.Physiol_25_185
Author(s) : Christopoulos A , Lanzafame A , Mitchelson F
Ref : Clinical & Experimental Pharmacology & Physiology , 25 :185 , 1998
Abstract : Christopoulos_1998_Clin.Exp.Pharmacol.Physiol_25_185
ESTHER : Christopoulos_1998_Clin.Exp.Pharmacol.Physiol_25_185
PubMedSearch : Christopoulos_1998_Clin.Exp.Pharmacol.Physiol_25_185
PubMedID: 9590567

Title : Poster: A common site of action for two allosteric antagonists -
Author(s) : Christopoulos A , Lanzafame A , Mitchelson F
Ref : Life Sciences , 60 :1173 , 1997
PubMedID:

Title : Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors - Lanzafame_1997_J.Pharmacol.Exp.Ther_282_278
Author(s) : Lanzafame A , Christopoulos A , Mitchelson F
Ref : Journal of Pharmacology & Experimental Therapeutics , 282 :278 , 1997
Abstract : Lanzafame_1997_J.Pharmacol.Exp.Ther_282_278
ESTHER : Lanzafame_1997_J.Pharmacol.Exp.Ther_282_278
PubMedSearch : Lanzafame_1997_J.Pharmacol.Exp.Ther_282_278
PubMedID: 9223565

Title : Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an infinite dilution procedure - Christopoulos_1997_Biochem.Pharmacol_53_795
Author(s) : Christopoulos A , Lanzafame A , Ziegler A , Mitchelson F
Ref : Biochemical Pharmacology , 53 :795 , 1997
Abstract : Christopoulos_1997_Biochem.Pharmacol_53_795
ESTHER : Christopoulos_1997_Biochem.Pharmacol_53_795
PubMedSearch : Christopoulos_1997_Biochem.Pharmacol_53_795
PubMedID: 9113100

Title : Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors - Lanzafame_1996_Eur.J.Pharmacol_316_27
Author(s) : Lanzafame A , Christopoulos A , Mitchelson F
Ref : European Journal of Pharmacology , 316 :27 , 1996
Abstract : Lanzafame_1996_Eur.J.Pharmacol_316_27
ESTHER : Lanzafame_1996_Eur.J.Pharmacol_316_27
PubMedSearch : Lanzafame_1996_Eur.J.Pharmacol_316_27
PubMedID: 8982646